Evidence map›Paper›PMID 31368584›Full record

ArticleThe EMBO journal2019

SALM1 controls synapse development by promoting F-actin/PIP2-dependent Neurexin clustering.

Marinka Brouwer, Fatima Farzana, Frank Koopmans, Ning Chen, Jessie W Brunner, Silvia Oldani, Ka Wan Li, Jan Rt van Weering, August B Smit, Ruud F Toonen and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Marinka BrouwerDepartment of Clinical Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
Fatima FarzanaDepartment of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
Frank KoopmansDepartment of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-4973-5732
Ning ChenDepartment of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
Jessie W BrunnerDepartment of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
Silvia OldaniDepartment of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
Ka Wan LiDepartment of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
Jan Rt van WeeringDepartment of Clinical Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
August B SmitDepartment of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.
Ruud F ToonenDepartment of Functional Genomics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-9900-4233
Matthijs VerhageDepartment of Clinical Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam and VU Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-2514-0216
Amsterdam Neuroscience · NL

Funding

European Research Council 322966ZonMw (Netherlands Organisation for Health Research and Development) 91111009
6 · The paper itself

Abstract

Synapse development requires spatiotemporally regulated recruitment of synaptic proteins. In this study, we describe a novel presynaptic mechanism of cis-regulated oligomerization of adhesion molecules that controls synaptogenesis. We identified synaptic adhesion-like molecule 1 (SALM1) as a constituent of the proposed presynaptic Munc18/CASK/Mint1/Lin7b organizer complex. SALM1 preferentially localized to presynaptic compartments of excitatory hippocampal neurons. SALM1 depletion in excitatory hippocampal primary neurons impaired Neurexin1β- and Neuroligin1-mediated excitatory synaptogenesis and reduced synaptic vesicle clustering, synaptic transmission, and synaptic vesicle release. SALM1 promoted Neurexin1β clustering in an F-actin- and PIP2-dependent manner. Two basic residues in SALM1's juxtamembrane polybasic domain are essential for this clustering. Together, these data show that SALM1 is a presynaptic organizer of synapse development by promoting F-actin/PIP2-dependent clustering of Neurexin.

Indexed as

ActinsAnimalsCalcium-Binding ProteinsCell Adhesion Molecules, NeuronalCells, CulturedHEK293 CellsHippocampusHumansMembrane GlycoproteinsMiceNerve Tissue ProteinsNeural Cell Adhesion MoleculesNeurogenesisPhosphatidylinositol 4,5-DiphosphateSynapsesActinsCalcium-Binding ProteinsCell Adhesion Molecules, NeuronalLrfn2 protein, mouseMembrane GlycoproteinsNerve Tissue ProteinsNeural Cell Adhesion Moleculesneuroligin 1Nrxn1 protein, mousePhosphatidylinositol 4,5-DiphosphateneurexinPIP2SALM1synapse organizationsynaptogenesis

Identifiers

PMID31368584
PMCPMC6717895
OpenAlexW2966590524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.